Quantcast
Channel: SingleCare articles by Jennifer Larson - The Checkup
Browsing latest articles
Browse All 22 View Live

The best diet while taking Mounjaro

Mounjaro (tirzepatide) is an injectable medication that is approved by the Food and Drug Administration (FDA) to help control blood sugar in people with Type II diabetes. Manufactured by Eli Lily and...

View Article


Who should not take quercetin?

Quercetin is a flavonoid, a compound that gives plants—including fruits, vegetables, herbs, and flowers—their color. It’s found in many common foods and drinks, such as citrus fruit, apples, onions,...

View Article


How long does hydroxyzine last?

Hydroxyzine is a first-generation antihistamine that can be used to treat a number of different conditions, including anxiety, insomnia, and allergic reactions like hives. This medication comes in...

View Article

FDA approves nasal spray for emergency allergic reactions

There’s a new needle-free treatment option for people at risk for life-threatening allergic reactions. On August 9, the U.S. Food and Drug Administration (FDA) approved neffy, a nasal spray for the...

View Article

Can you take MiraLAX every day?

If you feel like you need to go but just…can’t, you might be dealing with constipation. It’s a common problem—about 4 million people in the U.S. experience it regularly. While lifestyle modifications...

View Article


Can you eat pineapple if you have diabetes?

When choosing a food to snack on, fruit is a healthy, sweet treat—even if you have diabetes. Some people mistakenly believe you shouldn’t eat anything that tastes sugary if you live with this...

View Article

Using metoprolol to treat anxiety

Nearly a third of all Americans will experience an anxiety disorder at some point in their lives. When symptoms are severe, medication can help. Beta blockers are a class of drugs that works on your...

View Article

FDA issues warnings to GLP-1 compounders

Originally approved to help people with Type 2 diabetes, the class of medications known as GLP-1 agonists and dual GIP/GLP-1s  quickly acquired a reputation for helping people shed stubborn pounds. As...

View Article


FDA approves Zepbound for sleep apnea

The U.S. Food and Drug Administration (FDA) recently approved Zepbound (tirzepatide) as the first prescription drug for obstructive sleep apnea. Zepbound was first approved for chronic weight...

View Article


FDA approves first generic once-daily GLP-1 medication

As glucagon-like peptide-1 (GLP-1) receptor agonists continue to surge in popularity, the U.S. Food and Drug Administration approved the second generic in this class of medications: liraglutide...

View Article
Browsing latest articles
Browse All 22 View Live